C07D 513/14
Ortho-condensed systems
C07D513/14 (Ortho-condensed systems) appears on 420 US grants and 448 published applications in this corpus.
Search patents in C07D- Granted patents
- 420
- Published applications
- 448
- Assignees
- 287
- Inventors
- 1,667
- Latest grant
- 11 Aug 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 3 | 0 |
| 1977 | 0 | 0 |
| 1978 | 9 | 0 |
| 1979 | 5 | 0 |
| 1980 | 5 | 0 |
| 1981 | 5 | 0 |
| 1982 | 2 | 0 |
| 1983 | 1 | 0 |
| 1984 | 1 | 0 |
| 1985 | 3 | 0 |
| 1986 | 2 | 0 |
| 1987 | 6 | 0 |
| 1988 | 5 | 0 |
| 1989 | 7 | 0 |
| 1990 | 8 | 0 |
| 1991 | 6 | 0 |
| 1992 | 8 | 0 |
| 1993 | 4 | 0 |
| 1994 | 3 | 0 |
| 1995 | 4 | 0 |
| 1996 | 7 | 0 |
| 1997 | 12 | 0 |
| 1998 | 8 | 0 |
| 1999 | 2 | 0 |
| 2000 | 6 | 0 |
| 2001 | 4 | 1 |
| 2002 | 2 | 5 |
| 2003 | 6 | 9 |
| 2004 | 5 | 5 |
| 2005 | 6 | 10 |
| 2006 | 4 | 12 |
| 2007 | 4 | 7 |
| 2008 | 7 | 6 |
| 2009 | 4 | 16 |
| 2010 | 6 | 9 |
| 2011 | 12 | 25 |
| 2012 | 10 | 16 |
| 2013 | 18 | 22 |
| 2014 | 17 | 32 |
| 2015 | 24 | 17 |
| 2016 | 20 | 16 |
| 2017 | 16 | 21 |
| 2018 | 16 | 17 |
| 2019 | 12 | 20 |
| 2020 | 15 | 18 |
| 2021 | 13 | 28 |
| 2022 | 23 | 25 |
| 2023 | 13 | 32 |
| 2024 | 19 | 31 |
| 2025 | 16 | 29 |
| 2026 | 6 | 19 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Pyrazole-containing polycyclic derivative inhibitor, preparation method therefor and application thereof11 Aug 2026US 12,703,701 B2Jiangsu Hansoh Pharmaceutical Group Co., Ltd.
- Tricyclic triazolo compounds as DGK inhibitors28 Jul 2026US 12,692,276 B2Incyte Corporation
- Method for introducing deuterated lower alkyl into amine moiety of compound containing secondary amine19 May 2026US 12,630,487 B2Otsuka Pharmaceutical Co., Ltd.
- IRAK degraders and uses thereof3 Feb 2026US 12,539,295 B2Kymera Therapeutics, Inc.
- Prevention, prophylactic and therapeutic treatment of autoimmune diseases including multiple sclerosis using novel small molecules and compositions thereof27 Jan 2026US 12,534,478 B2University of Sharjah
- Nitrogenous heterocycles for organic electroluminescent devices17 Sep 2026US 2026/0282745 A1UDC Ireland Limited
- Imidazodiazepinediones and methods of use thereof27 Aug 2026US 2026/0250295 A1Gfb (Abc), LLC
- Degrader compounds of qsox1 mrna27 Aug 2026US 2026/0250738 A9University of Florida Research Foundation, Inc.
- Pharmaceutically effective compounds inhibiting selectively the myosin 2 isoforms13 Aug 2026US 2026/0234156 A1EöTvöS LoráNd TudomáNyegyetem
- Fused ring piperidine compound, and preparation method therefor and use thereof6 Aug 2026US 2026/0224590 A1Center for Excellence In Molecular Cell Science, Chinese Academy of Sciences
Most cited
By later US patents
- Oxazolo, thiazolo and selenazolo [4,5-c]-quinolin-4-amines and analogs thereof270US 6,110,929 A3M Innovative Properties Company · 2000
- Bicyclic compounds capable of inhibiting tyrosine kinases of the epidermal growth factor receptor family225US 5,654,307 AWarner-Lambert Company · 1997
- 4-Hydroxy-2H-1,2-benzothiazine-3-carboxamide-1,1-dioxides and salts thereof142US 4,233,299 ABoehringer Ingelheim GmbH · 1980
- Macrocyclic immunomodulators90US 5,457,111 AAbbott Laboratories · 1995
- Tricyclic compounds82US 8,426,411 B2Abbott Laboratories · 2013